These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18457955)

  • 1. Analogs of Eu3+ DOTAM-Gly-Phe-OH and Tm3+ DOTAM-Gly-Lys-OH: synthesis and magnetic properties of potential PARACEST MRI contrast agents.
    Suchý M; Li AX; Bartha R; Hudson RH
    Bioorg Med Chem; 2008 Jun; 16(11):6156-66. PubMed ID: 18457955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sensitive PARACEST contrast agent for temperature MRI: Eu3+-DOTAM-glycine (Gly)-phenylalanine (Phe).
    Li AX; Wojciechowski F; Suchy M; Jones CK; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2008 Feb; 59(2):374-81. PubMed ID: 18228602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A robust and convergent synthesis of dipeptide-DOTAM conjugates as chelators for lanthanide ions: new PARACEST MRI agents.
    Wojciechowski F; Suchy M; Li AX; Azab HA; Bartha R; Hudson RH
    Bioconjug Chem; 2007; 18(5):1625-36. PubMed ID: 17711349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new synthesis of cystamine modified Eu3+ DOTAM-Gly-Phe-OH: a conjugation ready temperature sensitive MRI contrast agent.
    Suchý M; Li AX; Bartha R; Hudson RH
    Org Biomol Chem; 2008 Oct; 6(19):3588-96. PubMed ID: 19082160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of MRI contrast agents derived from DOTAM-Gly-L-Phe-OH incorporating a disulfide bridge: conjugation to a cell penetrating peptide and preparation of a dimeric agent.
    Suchý M; Li AX; Bartha R; Hudson RH
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5521-6. PubMed ID: 20705462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOTAM-type ligands possessing arginine pendant groups for use in PARACEST MRI.
    Suchý M; Li AX; Milne M; Bartha R; Hudson RH
    Contrast Media Mol Imaging; 2012; 7(5):441-9. PubMed ID: 22821878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications.
    Aime S; Barge A; Delli Castelli D; Fedeli F; Mortillaro A; Nielsen FU; Terreno E
    Magn Reson Med; 2002 Apr; 47(4):639-48. PubMed ID: 11948724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous in vivo pH and temperature mapping using a PARACEST-MRI contrast agent.
    McVicar N; Li AX; Suchý M; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2013 Oct; 70(4):1016-25. PubMed ID: 23165779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A DOTAM-based paraCEST agent favoring TSAP geometry for enhanced amide proton chemical shift dispersion and temperature sensitivity.
    Stevens TK; Milne M; Elmehriki AA; Suchý M; Bartha R; Hudson RH
    Contrast Media Mol Imaging; 2013; 8(3):289-92. PubMed ID: 23606433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-pool modeling of proton exchange processes in biological systems in the presence of MRI-paramagnetic chemical exchange saturation transfer (PARACEST) agents.
    Li AX; Hudson RH; Barrett JW; Jones CK; Pasternak SH; Bartha R
    Magn Reson Med; 2008 Nov; 60(5):1197-206. PubMed ID: 18958857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of Peripheral Carboxylates to Decrease the Charge on Tm(3+) DOTAM-Alkyl Complexes: Implications for Detection Sensitivity and in Vivo Toxicity of PARACEST MRI Contrast Agents.
    Suchý M; Milne M; Elmehriki AA; McVicar N; Li AX; Bartha R; Hudson RH
    J Med Chem; 2015 Aug; 58(16):6516-32. PubMed ID: 26214576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved synthesis of DOTA tetraamide ligands for lanthanide(III) ions: a tool for increasing the repertoire of potential PARACEST contrast agents for MRI and/or fluorescent sensors.
    De León-Rodríguez LM; Viswanathan S; Sherry AD
    Contrast Media Mol Imaging; 2010; 5(3):121-5. PubMed ID: 20586036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic PARACEST contrast agents for magnetic resonance imaging.
    Pikkemaat JA; Wegh RT; Lamerichs R; van de Molengraaf RA; Langereis S; Burdinski D; Raymond AY; Janssen HM; de Waal BF; Willard NP; Meijer EW; Grüll H
    Contrast Media Mol Imaging; 2007; 2(5):229-39. PubMed ID: 17937448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo detection of MRI-PARACEST agents in mouse brain tumors at 9.4 T.
    Li AX; Suchy M; Li C; Gati JS; Meakin S; Hudson RH; Menon RS; Bartha R
    Magn Reson Med; 2011 Jul; 66(1):67-72. PubMed ID: 21254213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARACEST agents: modulating MRI contrast via water proton exchange.
    Zhang S; Merritt M; Woessner DE; Lenkinski RE; Sherry AD
    Acc Chem Res; 2003 Oct; 36(10):783-90. PubMed ID: 14567712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The thulium complex of 1,4,7,10-tetrakis{[N-(1H-imidazol-2-yl)carbamoyl]methyl}-1,4,7,10-tetraazacyclododecane (dotami) as a ParaCEST contrast agent.
    Burdinski D; Lub J; Pikkemaat JA; Langereis S; Grüll H; Ten Hoeve W
    Chem Biodivers; 2008 Aug; 5(8):1505-1512. PubMed ID: 18729087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterisation of a diprotonated ligand lanthanide complex--a key intermediate in lanthanide ion association and complex dissociation pathways.
    Stenson PA; Thompson AL; Parker D
    Dalton Trans; 2006 Jul; (27):3291-3. PubMed ID: 16820839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triethylenetetramine penta- and hexa-acetamide ligands and their ytterbium complexes as paraCEST contrast agents for MRI.
    Burdinski D; Lub J; Pikkemaat JA; Moreno Jalón D; Martial S; Del Pozo Ochoa C
    Dalton Trans; 2008 Aug; (31):4138-51. PubMed ID: 18688432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrocyclic Gd3+ chelates attached to a silsesquioxane core as potential magnetic resonance imaging contrast agents: synthesis, physicochemical characterization, and stability studies.
    Henig J; Tóth E; Engelmann J; Gottschalk S; Mayer HA
    Inorg Chem; 2010 Jul; 49(13):6124-38. PubMed ID: 20527901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ParaCEST MRI contrast agents capable of derivatization via"click" chemistry.
    Milne M; Chicas K; Li A; Bartha R; Hudson RH
    Org Biomol Chem; 2012 Jan; 10(2):287-92. PubMed ID: 22069041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.